Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

DPhil Study Day Logo

This year’s 14th Annual Medical Sciences DPhil Day, a student-organised symposium, proudly showcased the varied and excellent biomedical and clinical research carried out by DPhil students across the Medical Sciences Division.

The event gave students the opportunity to present to their peers and see an exciting cross-section of ongoing research at Oxford’s many research sites.

3.JPG

Over 100 attendees attended 15 student talks covering a wide breadth of topics including neuroscience, organ transplantation, structural biology and vaccine design. Prizes were awarded to Malte Kaller (1st) and Janine Grey (2nd) for their outstanding presentations on myelination and drug development and active audience involvement was recognised with a prize for the best audience question awarded to Lancelot Millar. Students were also given the opportunity to present their posters with prizes awarded to Layal Liverpool (1st) and Amy Flaxman (2nd) for their work on host-viral interactions and microbiomes, respectively.

5.JPG

In addition to student presentations, Naomi Gibson, MSD Public Engagement Coordinator, spoke to students on the topic of Public Engagement, its increasing importance and how students can become involved as an integral part of their research careers.

The keynote lecture was provided by Professor Eleanor Riley of The London School of Hygiene and Tropical Medicine. Soon to take up a new post as Director of the Roslin Institute at Edinburgh University, we would like to thank Professor Riley for taking time travel to Oxford and share her insights from a long and inspiring career in multidisciplinary infectious disease research and malaria immunology.

2.JPG

The organising committee would also like to extend their thanks to Jane Rudman, Professor Afsie Sabokbar, Veliborka Milivojevic, our sponsors*, and to all the students who attended and presented their research for making the event a great success.

If you are interested in joining the organising committee for the 2018 event, please contact us or Jane Rudman for more information.

DPhil Day 2017 Committee

Agata Antepowicz, Alice Stelfox, Kento Kawai, Francesca Donnellan and Norbert Volkmar

 

Our sponsors

*Gilson, MACS Miltenyi Biotec, PeproTech, Sarstedt, Triplered

Similar stories

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.